Tesamorelin Benefits: Visceral Fat Evidence, Weight-Neutral Results and Important Limits
Review tesamorelin benefits in human trials, its FDA-approved HIV-lipodystrophy use, visceral-fat results, weight-neutral effect and safety limits.
AOD-9604 Benefits: Why the Largest Weight-Loss Trial Matters Most
Review AOD-9604 benefits, early human signals, the largest 24-week obesity trial, safety limits and what research buyers should verify.
Selank Benefits: What Small Human Studies Show—and What They Cannot Prove
Review Selank benefits, small anxiety-disorder studies, proposed GABA and enkephalin mechanisms, FDA concerns and the evidence still missing.
TB-500 Benefits: Why Thymosin Beta-4 Research Is Not the Same Evidence
Review TB-500 benefits, the seven-amino-acid fragment, thymosin beta-4 studies, FDA findings and the evidence human research has not established.
Ipamorelin Benefits: What Human Studies Actually Show
Review Ipamorelin benefits, GH-release studies, the failed postoperative-ileus trial, FDA findings and claims human research has not proved.
BPC-157 Benefits: What the Evidence Shows for People, Injuries and Older Dogs
Review BPC-157 research on tendons, joints, gut models and older dogs, including pet-owner reports, veterinary cases and major evidence gaps.
GHK-Cu Benefits: What Research Shows About Skin, Repair and Hair
Explore GHK-Cu research on skin, tissue repair and hair, with a clear distinction between cell, animal and limited human evidence.
NAD+ Benefits: What It Does in Cells and What Human Research Actually Shows
What does NAD+ do? Review its roles in energy metabolism, DNA repair and cell signalling—and why human anti-ageing benefits remain unproven.
Cloudy or Thick Tesamorelin: What the Appearance Can—and Cannot—Tell a Buyer
Tesamorelin looks cloudy, milky or gel-like after liquid is added? Learn what appearance cannot prove and which lot records a B2B enquiry needs.
